ischemic benefit vs. hemorrhagic risk in the thales dual antiplatelet therapy trial
Published 3 years ago • 262 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
22:27
dual antiplatelet therapy vs alteplase for patients with acute ischemic stroke
-
30:07
the changing face of dual anti-platelet therapy: implications for the internist
-
4:20
stratification of ischemic and hemorrhagic stroke risk in patients with atrial fibrillation
-
13:32
is 1-month dual antiplatelet therapy safe? reconciling master dapt and stopdapt-2
-
57:37
a case-based approach: finding balance between bleeding and ischemic risk - europcr 2021
-
1:22
heart minute | dual antiplatelet therapy after ischemic stroke or tia
-
21:23
jc: ticagrelor in acute ischemic stroke (thales)
-
0:48
dual anti platelet therapy’s affect on blood vessels #stroke #platelets #neurology
-
32:52
clopidogrel and aspirin in acute ischemic stroke and high-risk tia lessons from the point trial
-
13:40
ischemic stroke - causes, symptoms, diagnosis, treatment, pathology
-
7:14
acs management following dual antiplatelet therapy
-
21:14
antiplatelet therapy to prevent stroke: where does aspirin fit in?
-
8:02
april trial: aptoll demonstrates neuroprotective effects in acute ischemic stroke
-
0:59
ischemic stroke management following thrombolysis
-
56:18
the conundrum of antithrombotic therapy in atrial fibrillation patients undergoing tavi-europcr 2022
-
0:31
what happens during an ischemic stroke
-
5:27
dual antiplatelet therapy: whiteboard animation
-
8:14
stroke diagnosis and treatment - acute and long term treatment of ischemic and hemorrhagic stroke
-
2:06
new anti platelet drugs for cardiovascular disease and thrombosis